I would not say mostly, although clinical trials are a large part of the cost. (Roughly speaking) For every drug that makes it through final approval, there are ten that failed in trials. However, for every drug that makes it into trials, there were ten that didn't - and the R&D for those unseen drugs is also a huge cost for pharma companies.